徐州宝妈们斗几个月做的四维(徐州哪里有做4维彩超) (今日更新中)

LAS VEGAS, the United States, Jan. 12 (Xinhua) -- One of the most revolutionary changes for consumers that may come out of this year's International Consumer Electronics Show (CES) will not be the electronic devices themselves, but the way they are charged.Instead of using traditional cords to power mobile phones, kitchen appliances, and even vehicles, exhibits showcasing wireless power technologies offer a glimpse into the future of how individuals can charge their devices without a plug or cord.Fulton Innovation, who develops and licenses its eCoupled intelligent wireless technology, demonstrated how the technology could be applied across a variety of usage cases at home and at work.At CES, the company announced that it is releasing its next generation wireless power solutions that incorporate near-field resonant magnetic induction, allowing devices to charge without actually touching a charging surface.Additionally, it will allow power to transfer through metal surfaces, a property which had previously been unsafe to use as a surface conductor for power.While the products with integrated eCoupled capabilities currently in the marketplace focus predominantly on smartphone charging surfaces, in part due to the low-power demands of these devices, the company said there will be more applications using this technology expected to come to market in the near future.A large part of the added production scale on the consumer level is due to the standardization of the industry.In 2010, the Wireless Power Consortium (WPC) announced the finalization of the "Qi" standard, enabling interoperability for wireless charging between a power-providing device and electronics receiving power.Currently, the Qi standard is only applicable for the wireless transmission of power up to five watts, and the WPC is undertaking steps to expand this standard to deliver up to 120 watts of power.This standardization enables technology designers like Fulton Innovations to create underlying IP designs and technologies that work across a number of OEMs.The WPC currently has over 100 member companies, including Fulton Innovation, Nokia, Samsung, Haier, and Huawei Technologies.Fulton Innovation also expects to add its eCoupled technology to cars, giving automobile manufacturers the ability to install integrated charging platforms for mobile devices without additional wires or cords.Chinese auto makers Geely, Chery, Chang'an, and Dongfeng were the first to showcase cars at a major auto show featuring Qi standard charging stations during the April 2011 Shanghai Auto Show.The WPC estimates that there will be approximately five auto manufacturers who will release cars with Qi-enabled charging capabilities either late this year or early next year.

WASHINGTON, Nov. 7 (Xinhua) -- U.S. researchers have demonstrated for the first time that the brain is a key player in regulating glucose (sugar) metabolism in humans.The findings, published Monday in the online edition of the Journal of Clinical Investigation, suggest that drugs targeting the brain and central nervous system could be a novel approach to treating diabetes."The brain is the body's only organ that needs a constant supply of glucose to survive, so it makes sense that it would have some say over how much glucose is produced," said study leader Meredith Hawkins, professor of medicine and director of the Global Diabetes Initiative at Yeshiva University, in a statement. "This role for the brain was demonstrated in earlier studies in rodents, but there was considerable controversy over whether the results could be applied to humans. We hope this study helps to settle the matter."In an earlier study in rodents, researchers showed that activation of potassium channels in the brain's hypothalamus sends signals to the liver that dampen its production of glucose. Those findings, published in Nature in 2005, challenged the conventional thinking that blood sugar production by the liver (the body's glucose factory) is regulated only by the pancreas (which makes insulin to metabolize glucose). But carefully performed studies on dogs, conducted at Vanderbilt University, failed to replicate the results, suggesting the Einstein findings in rodents might not be relevant to higher mammals, including humans.The current study, involving people, was aimed at resolving this controversy. Ten nondiabetic subjects were given oral diazoxide, a drug that activates potassium channels in the hypothalamus. (The drug is not used to treat diabetes.) Hormone secretion by the pancreas was controlled to ensure that any change in sugar production would only have occurred through the drug's effect on the brain. After the researchers administered the drug, blood tests revealed that patients' livers were producing significantly less glucose than before.Hawkins and her team then repeated this in rats, again giving diazoxide orally, achieving similar results. They confirmed that sufficient amounts of diazoxide crossed the blood-brain barrier to affect potassium channels in the hypothalamus. Additional experiments confirmed that diazoxide was working through the brain. Specifically, the researchers were able to completely block the effects of diazoxide by infusing a specific potassium channel blocker directly into the brain."This study confirms that the brain plays a significant role in regulating glucose production by the liver," said lead author Preeti Kishore, assistant professor of medicine. "We are now investigating whether this 'brain-to-liver' pathway is impaired in people with diabetes. If so, we may be able to restore normal glucose regulation by targeting potassium channels in the brain."

SAN FRANCISCO, Dec. 13 (Xinhua) -- Apple is in talks to acquire Israeli fabless semiconductor maker Anobit for 400 million to 500 million U.S. dollars, U.S. media reported on Tuesday.Apple is likely interested in Herzliya Pituach, Israel-based Anobit for an exclusive access to its embedded flash controllers which can significantly boost memory performance of smartphones and tablet computers, said technology news site TechCrunch, citing Calcalist, an Israeli newspaper in Hebrew which first reported the possible acquisition.Apple already uses Anobit's technology in iPhone, iPad and the MacBook Air.If the deal works out, it could be Apple's largest acquisition ever, surpassing its 404 million-dollar purchase of NeXT in 1997.It could also become Apple's first acquisition in Israel and the first with Tim Cook as the chief executive officer of the company since its iconic leader Steve Jobs passed away in early October.

NEW YORK, Dec. 1 (Xinhua) -- New York City Mayor Michael Bloomberg announced on Thursday a new recommendation that doctors offer every person with an HIV diagnosis antiretroviral treatment to help them live longer and prevent transmission.This marks a change from the current practice that treatment only be offered to those who show signs of damage to their immune systems, said the mayor during the annual World AIDS Day commemorative ceremony at Gracie Mansion. "Over the past ten years HIV diagnoses and deaths in New York City have seen a dramatic decline," said Mayor Bloomberg. "Steady progress in our fight against HIV has turned what used to be a death sentence into a disease that can be prevented and, with antiretroviral therapy, managed.The annual death toll from HIV in the city is down by more than a third: 933 deaths in 2009Despite this progress, however, more than 110,000 people in New York City are infected with HIV, more than in any other U.S. city and about 75 percent of all cases in the New York State.Figures from the New York City Health and Hospitals Corporation (HHC) showed that HHC has tested more than one million New Yorkers for HIV since 2005 when the public hospitals and health centers began offering HIV screening as a routine part of medical care for patients aged 13 to 64.

来源：资阳报